ACST - Acasti Pharma Inc


3.435
0.415   12.082%

Share volume: 0
Last Updated: 10-25-2024

PREVIOUS CLOSE
CHG
CHG%

$3.02
0.42
13.74%
This ticker is disabled and data are no longer maintained and up to date.
Company vs Stock growth
vs
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
1.63%
1 Year
8.93%
2 Year
-23.77%
Key data
Stock price
$3.44
P/E Ratio 
0.00
DAY RANGE
$2.80 - $3.02
EPS 
$0.00
52 WEEK RANGE
$2.32 - $3.59
52 WEEK CHANGE
$12.68
MARKET CAP 
26.566 M
YIELD 
N/A
SHARES OUTSTANDING 
10.140 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.45
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Janelle D'Alvise
Region: US
Website: https://www.acastipharma.com/
Employees: 33
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.

Recent news